Skip to main content
. 2018 Mar 21;8(20):11163–11176. doi: 10.1039/c8ra00720a

Fig. 2. (a) Mean plasma concentration–time profiles of 3o after IV and PO dose in ICR mice (n = 3) (mean ± sd). (b) Mean lung concentration–time profiles of 3o after IV and PO dose in ICR mice (n = 3) (mean ± sd). (c) Mean plasma concentration–time profiles of PBTZ169 after IV and PO dose in ICR mice (n = 3) (mean ± sd). (d) Mean lung concentration–time profiles of PBTZ169 after IV and PO dose in ICR mice (n = 3) (mean ± sd).

Fig. 2